AAAAAA

   
Results: 1-17 |
Results: 17
Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance
Authors: Millon, R Muller, D Schultz, I Salvi, R Ghnassia, JP Frebourg, T Wasylyk, B Abecassis, J
Citation: R. Millon et al., Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance, ORAL ONCOL, 37(8), 2001, pp. 620-631
Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population
Authors: Ralhan, R Agarwal, S Nath, N Mathur, M Wasylyk, B Srivastava, A
Citation: R. Ralhan et al., Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population, ORAL ONCOL, 37(3), 2001, pp. 243-250
The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
Authors: Argentini, M Barboule, N Wasylyk, B
Citation: M. Argentini et al., The contribution of the acidic domain of MDM2 to p53 and MDM2 stability, ONCOGENE, 20(11), 2001, pp. 1267-1275
Net, an Ets ternary complex transcription factor, is expressed in sites ofvasculogenesis, angiogenesis, and chondrogenesis during mouse development
Authors: Ayadi, A Suelves, M Dolle, P Wasylyk, B
Citation: A. Ayadi et al., Net, an Ets ternary complex transcription factor, is expressed in sites ofvasculogenesis, angiogenesis, and chondrogenesis during mouse development, MECH DEVEL, 102(1-2), 2001, pp. 205-208
Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2
Authors: Sengupta, S Wasylyk, B
Citation: S. Sengupta et B. Wasylyk, Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2, GENE DEV, 15(18), 2001, pp. 2367-2380
Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1
Authors: Ayadi, A Zheng, H Sobieszczuk, P Buchwalter, G Moerman, P Alitalo, K Wasylyk, B
Citation: A. Ayadi et al., Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1, EMBO J, 20(18), 2001, pp. 5139-5152
Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinaseinhibitor gene and human oral cancer
Authors: Ralhan, R Agarwal, S Mathur, M Wasylyk, B Srivastava, A
Citation: R. Ralhan et al., Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinaseinhibitor gene and human oral cancer, CLIN CANC R, 6(6), 2000, pp. 2440-2447
The ternary complex factor Net contains two distinct elements that mediatedifferent responses to MAP kinase signalling cascades
Authors: Ducret, C Maira, SM Lutz, Y Wasylyk, B
Citation: C. Ducret et al., The ternary complex factor Net contains two distinct elements that mediatedifferent responses to MAP kinase signalling cascades, ONCOGENE, 19(44), 2000, pp. 5063-5072
The contribution of the RING finger domain of MDM2 to cell cycle progression
Authors: Argentini, M Barboule, N Wasylyk, B
Citation: M. Argentini et al., The contribution of the RING finger domain of MDM2 to cell cycle progression, ONCOGENE, 19(34), 2000, pp. 3849-3857
Tumour regression in a ligand inducible manner mediated by a chimeric tumour suppressor derived from p53
Authors: Sengupta, S Ralhan, R Wasylyk, B
Citation: S. Sengupta et al., Tumour regression in a ligand inducible manner mediated by a chimeric tumour suppressor derived from p53, ONCOGENE, 19(3), 2000, pp. 337-350
Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells
Authors: Wasylyk, C Wasylyk, B
Citation: C. Wasylyk et B. Wasylyk, Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells, MOL CELL B, 20(15), 2000, pp. 5554-5570
Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells
Authors: Sengupta, S Vonesch, JL Waltzinger, C Zheng, H Wasylyk, B
Citation: S. Sengupta et al., Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells, EMBO J, 19(22), 2000, pp. 6051-6064
MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis
Authors: Ganguli, G Abecassis, J Wasylyk, B
Citation: G. Ganguli et al., MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis, EMBO J, 19(19), 2000, pp. 5135-5147
MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice
Authors: Alkhalaf, M Ganguli, G Messaddeq, N Le Meur, M Wasylyk, B
Citation: M. Alkhalaf et al., MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice, ONCOGENE, 18(7), 1999, pp. 1419-1434
p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
Authors: Wasylyk, C Salvi, R Argentini, M Dureuil, C Delumeau, I Abecassis, J Debussche, L Wasylyk, B
Citation: C. Wasylyk et al., p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53, ONCOGENE, 18(11), 1999, pp. 1921-1934
The net repressor is regulated by nuclear export in response to anisomycin, UV, and heat shock
Authors: Ducret, C Maira, SM Dierich, A Wasylyk, B
Citation: C. Ducret et al., The net repressor is regulated by nuclear export in response to anisomycin, UV, and heat shock, MOL CELL B, 19(10), 1999, pp. 7076-7087
Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation
Authors: Criqui-Filipe, P Ducret, C Maira, SM Wasylyk, B
Citation: P. Criqui-filipe et al., Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation, EMBO J, 18(12), 1999, pp. 3392-3403
Risultati: 1-17 |